TABLE 1.
Characteristic | Intervention group (n = 16) | Control group (n = 21) |
---|---|---|
Age, y | 55 [35–62] | 52 [38–62] |
Sex, n (M/F) | 6/10 | 6/15 |
Smoking, % yes | 12.5 | 14.3 |
Alcohol intake, units/wk | 2 [1–5] | 3 [0–5] |
BMI, kg/m2 | 34.1 [28.8–37.3] | 31.1 [30.2–35.6] |
Waist circumference, cm | 117.9 [106.5–128.4] | 110.0 [104.3–113.6] |
HOMA2-IR | 0.84 [0.50–1.37] | 0.86 [0.73–1.14] |
Serum total cholesterol, mmol/L | 5.2 [4.3–5.6] | 5.2 [4.2–6.0] |
Serum HDL cholesterol, mmol/L | 1.2 [1.1–1.3] | 1.3 [1.0–1.5] |
Serum LDL cholesterol, mmol/L | 3.1 [2.3–3.8] | 2.7 [2.3–3.8] |
Serum triglycerides, mmol/L | 1.6 [1.2–1.9] | 1.3 [0.9–1.7] |
Dietary fructose intake, g/d | 42.1 [20.3–73.4] | 36.9 [27.1–54.6] |
Fatty liver index | 94 [74–96] | 84 [64–91] |
Intrahepatic lipid content, % | 4.9 [2.3–10.3] | 2.1 [0.9–7.7] |
1Values are medians [IQRs]. HOMA2-IR, homeostasis model assessment of insulin resistance.